Physical and Mental Fatigue in Parkinson’s DiseaseEpidemiology, Pathophysiology and Treatment

被引:0
|
作者
Jau-Shin Lou
机构
[1] Oregon Health & Science University,Department of Neurology, CR120
来源
Drugs & Aging | 2009年 / 26卷
关键词
Transcranial Magnetic Stimulation; Maximal Voluntary Contraction; Modafinil; Mental Fatigue; Fatigue Severity Scale;
D O I
暂无
中图分类号
学科分类号
摘要
Fatigue is one of the most common non-motor complaints of Parkinson’s disease (PD) patients and is associated with reduced activity and poorer quality of life. Fatigue can be experienced as a state of being tired or weary (subjective fatigue) or as a process of becoming tired or fatigued (fatigability). Subjective mental and physical fatigue are evaluated using self-report questionnaires such as the Multidimensional Fatigue Inventory. Physical fatigability is studied in a laboratory setting using physical exercise protocols and transcranial magnetic stimulation. Mental fatigability is evaluated by measuring attention over time using a reaction-time paradigm called the Attention Network Test (ANT).
引用
收藏
页码:195 / 208
页数:13
相关论文
共 50 条
  • [1] Physical and Mental Fatigue in Parkinson's Disease Epidemiology, Pathophysiology and Treatment
    Lou, Jau-Shin
    DRUGS & AGING, 2009, 26 (03) : 195 - 208
  • [2] Depression in Patients with Parkinson’s DiseaseEpidemiology, Pathophysiology and Treatment Options
    Theresa A. Zesiewicz
    Robert A. Hauser
    CNS Drugs, 2000, 13 : 253 - 264
  • [3] Postural Instability in Patients with Parkinson’s DiseaseEpidemiology, Pathophysiology and Management
    Samuel D. Kim
    Natalie E. Allen
    Colleen G. Canning
    Victor S. C. Fung
    CNS Drugs, 2013, 27 : 97 - 112
  • [4] Sleep Disturbances in Patients with Alzheimer’s DiseaseEpidemiology,Pathophysiology and Treatment
    Michael V. Vitiello
    Soo Borson
    CNS Drugs, 2001, 15 : 777 - 796
  • [5] Exacerbated physical fatigue and mental fatigue in Parkinson's disease
    Lou, JS
    Kearns, G
    Oken, B
    Sexton, G
    Nutt, J
    MOVEMENT DISORDERS, 2001, 16 (02) : 190 - 196
  • [6] Gastrointestinal Motility Problems in Patients with Parkinson’s DiseaseEpidemiology Pathophysiology and Guidelines for Management
    Ronald F. Pfeiffer
    Eamonn M. M. Quigley
    CNS Drugs, 1999, 11 : 435 - 448
  • [7] Darier’s DiseaseEpidemiology, Pathophysiology, and Management
    Susan M. Cooper
    Susan M. Burge
    American Journal of Clinical Dermatology, 2003, 4 : 97 - 105
  • [8] Sleep Disorders in Parkinson’s DiseaseEpidemiology and Management
    Mark Stacy
    Drugs & Aging, 2002, 19 : 733 - 739
  • [9] Physical and mental fatigue in Parkinson's Disease: analysis from COPPADIS database
    Morales-Casado, M. I.
    Lopez-Ariztegui, N.
    Oliviero, A.
    Soto-Leon, V.
    Segundo-Rodriguez, J. C.
    Deus Fonticoba, T.
    Jesus, S.
    Aguilar, M.
    Pastor, P.
    Planellas, L. L.
    Cosgaya, M.
    Garcia-Caldentey, J.
    Caballol, N.
    Vives, B.
    Hernandez-Vara, J.
    Cabo, I.
    Lopez-Manzanares, L.
    Gonzalez-Aramburu, I.
    Avila-Rivera, M. A.
    Catalan, M. J.
    Nogueira, V.
    Puente, V.
    Ruiz-de Arcos, M.
    Borrue, C.
    Solano-Vila, B.
    Alvarez-Sauco, M.
    Vela, L.
    Escalante, S.
    Cubo, E.
    Carrillo-Padilla, F.
    Martinez-Castrillo, J. C.
    Sanchez-Alonso, P.
    Alonso-Losada, M. G.
    Clavero, P.
    Kulisevsky, J.
    Blazquez-Estrada, M.
    Seijo, M.
    Ruiz-Martinez, J.
    Valero, C.
    Kurtis, M.
    de Fabregues, O.
    Gonzalez-Ardura, J.
    Ordas, C.
    Lopez-Diaz, L.
    Mir, P.
    Martinez-Martin, P.
    Santos-Garcia, D.
    MOVEMENT DISORDERS, 2021, 36 : S427 - S427
  • [10] Pathophysiology and treatment on Parkinson's disease
    Shimohama, Shun
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2005, 125 : 64 - 67